Zentalis Pharmaceuticals, Inc. (ZNTL) Net income 2019–2025
Zentalis Pharmaceuticals, Inc. (ZNTL) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$137.1MFY2025 · since FY2019: -$45.7M → -$137.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$137.1M | +17.4% |
| FY2024 | -$165.8M | +43.2% |
| FY2023 | -$292.2M | -23.4% |
| FY2022 | -$236.8M | -49.2% |
| FY2021 | -$158.7M | -34.7% |
| FY2020 | -$117.8M | -158.1% |
| FY2019 | -$45.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ZNTL financial trends
ZNTL RevenueZNTL Net marginZNTL Gross profitZNTL Gross marginZNTL Operating incomeZNTL Operating marginZNTL Operating cash flowZNTL Free cash flowZNTL Capital expendituresZNTL Return on equityZNTL Stock buybacksZNTL Dividends paidZNTL Total assetsZNTL Total liabilitiesZNTL Shareholders’ equityZNTL overview →